THERAPEUTIC AREA: ACTIVE PRINCIPLE: Simoctocog alfa (Human coagulation factor VIII, recombinant) PRESENTATION: 2.000 UI, 1.000 UI, 500 UI and 250 UI Lyophilized Powder for reconstitution INDICATION:
COUNTRIES WHERE IT IS MARKETED:
